Int Neurourol J.  2022 Dec;26(4):308-316. 10.5213/inj.2244146.073.

A Multicenter, Open-Label, Observational Study Evaluating the Quality of Life After Using a Hydrophilic-Coated Catheter (SpeediCath) With Self-Intermittent Catheterization

• Ko KJ
• Choo MS
• Kim SO
• Kim JH
• Chung KJ
• Yoo ES
• Kim MK
• Cho WJ
• Choi JB
• Lee J
• Lee KS

• KMID: 2537307
• DOI: http://doi.org/10.5213/inj.2244146.073

Abstract

Purpose
We evaluated the change in patient quality of life after the use of a hydrophilic-coated catheter (SpeediCath) in adults requiring intermittent catheterization (IC).
Methods
This was a multicenter, open-label, observational study using the Patient Perception of Intermittent Catheterization (PPIC) questionnaire and the Intermittent Self-Catheterization questionnaire (ISC-Q) and safety at 12 and 24 weeks in adult patients who had already used other type of catheters prior to switching to SpeediCath or in patients undergoing self-IC for the first time for any reason.
Results
Among a total of 360 subjects, 215 (59.7%) were women, and the mean age was 62.0±13.2 years. At 24 weeks, the satisfaction rate after using SpeediCath was 84.1%, and 80% of patients responded that they could easily perform IC. In total, 81.6% of patients were willing to continue using SpeediCath. The mean ISC-Q score was 54.90±18.65 at 24 weeks. Men found less interference in their daily life by performing IC than women and found it easier to handle the catheter before it was inserted into the urethra. At week 12, the mean change in ISC-Q was significantly greater in patients <65 years (20.24±23.55) than in those ≥65 years (7.57±27.70, P=0.049), but there was no difference at 24 weeks. The most common adverse events were urinary tract infection in 9.72%, gross hematuria in 2.78%, and urethral pain in 1.39%.
Conclusions
The use of a SpeediCath provided good quality of life for patients who needed self-IC regardless of age or sex.

Keyword

Bladder; Intermittent catheterization; Quality of life; Urinary retention